Neuropharm
Neuropharm, an AIM-listed speciality pharmaceutical group, develops and markets new drugs for patients with unmet medical needs. The group is presently working towards a treatment for autism which would dramatically improve the quality of life for those touched by the condition – currently millions of patients and carers worldwide.
Cherry provided copy for Neuropharm's new corporate site, with design and build by communications agency Radley Yeldar.
